Since P-gp efflux function was shown to contribute to TRAIL resistance via controlling the endogenous level of TRAIL in certain types of cancer cells55,56, such an anti-Pgp activity of pinoresinol might constitute another mechanism in enhancing TRAIL efficacy in TRAIL-resistant cancers including glioblastoma. The gene discussed is PGP; the disease is glioblastoma.